17β-estradiol- and 4-hydroxytamoxifen-induced transactivation in breast, endometrial and liver cancer cells is dependent on ER-subtype, cell and promoter context

Journal of Steroid Biochemistry and Molecular Biology

Volumn 84, Issue 1, 2003, Pages 23-31

  Castro Rivera, Emely ^a   Safe, Stephen ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

17 Estradiol; 4 Hydroxytamoxifen; Cancer cells; Promoters; Transactivation

Indexed keywords

4 HYDROXYTAMOXIFEN; CATHEPSIN D; COMPLEMENT COMPONENT C3; CREATINE KINASE; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; RECEPTOR SUBTYPE; TRANSCRIPTION FACTOR;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL STRAIN HEPG2; CELL TYPE; CONTROLLED STUDY; DRUG ACTIVITY; ENDOMETRIUM CANCER; GENE ACTIVITY; GENE CONSTRUCT; GENE INSERTION; GENETIC TRANSFECTION; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HUMAN CELL; LIVER CANCER; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN VARIANT; TRANSACTIVATION; TRANSCRIPTION INITIATION;

EID: 0037225924     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(03)00010-4     Document Type: Article

References (47)

1. Tsai M.J., O'Malley B.W. Molecular mechanisms of action of steroid-thyroid receptor superfamily members. Annu. Rev. Biochem. 63:1994;451-486.
2. N.H. Ing, B.W. O'Malley, The steroid hormone receptor superfamily: molecular mechanisms of action, in: B.D. Weintraub (Ed.), Molecular Endocrinology: Basic Concepts and Clinical Correlations, Raven Press Ltd., New York, 1995, pp. 195-215.
3. J.H. Clark, W.T. Schrader, B.W. O'Malley, Mechanisms of action of steroid hormones, in: J.D. Wilson, D.W. Foster (Eds.), Textbook of Endocrinology, Saunders, New York, 1992, pp. 35-90.
4. Kuiper G.G., Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson J.A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U.S.A. 93:1996;5925-5930.
5. Mosselman S., Polman J., Dijkema R. ERβ: identification and characterization of a novel human estrogen receptor. FEBS Lett. 392:1996;49-53.
6. Enmark E., Pelto-Huikko M., Grandien K., Lagercrantz S., Lagercrantz J., Fried G., Nordenskjold M., Gustafsson J.A. Human estrogen receptor β-gene structure, chromosomal localization, and expression pattern. J. Clin. Endocrinol. Metab. 82:1997;4258-4265.
7. Tremblay G.B., Tremblay A., Copeland N.G., Gilbert D.J., Jenkins N.A., Labrie F., Giguère V. Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor β Mol. Endocrinol. 11:1997;353-365.
8. Ogawa S., Inouse S., Watanabe T., Hiroi H., Orimo A., Hosoi T., Ouchi Y., Muramatsu M. The complete primary structure of human estrogen receptor β (hERβ) and its hetero-dimerization with ERα in vivo and in vitro. Biochem. Biophys. Res. Commun. 243:1998;122-126.
9. Pettersson K., Brandien K., Kuiper G.G., Gustafsson J.-Å. Mouse estrogen receptor β forms estrogen response element-binding hetero-dimers with estrogen receptor α Mol. Endocrinol. 11:1997;1486-1496.
10. Walther N., Lioutas C., Tillmann G., Ivell R. Cloning of bovine estrogen receptor β (ERβ): expression of novel deleted iso-forms in reproductive tissues. Mol. Cell Endocrinol. 152:1999;37-45.
11. Cowley S.M., Hoare S., Mosselman S., Parker M.G. Estrogen receptors α and β form hetero-dimers on DNA. J. Biol. Chem. 272:1997;19858-19862.
12. Pace P., Taylor J., Suntharalingam S., Coombes R.C., Ali S. Human estrogen receptor β binds DNA in a manner similar to and dimerizes with estrogen receptor α J. Biol. Chem. 272:1997;25832-25838.
13. Tremblay A., Tremblay G.B., Labrie C., Labrie F., Giguere V. EM-800, a novel antiestrogen, acts as a pure antagonist of the transcriptional functions of estrogen receptors α and β Endocrinology. 139:1998;111-118.
14. Watanabe T., Inoue S., Ogawa S., Ishii Y., Hiroi H., Ikeda K., Orimo A., Muramatsu M. Agonistic effect of tamoxifen is dependent on cell type, ERE-promoter context, and estrogen receptor subtype: functional difference between estrogen receptors α and β Biochem. Biophys. Res. Commun. 236:1997;140-145.
15. Jones P.S., Parrott E., White I.N. Activation of transcription by estrogen receptors α and β is cell type- and promoter-dependents. J. Biol. Chem. 274:1999;32008-32014.
16. Barkhem T., Carlsson B., Nilsson Y., Enmark E., Gustafsson J., Nilsson S. Differential response of estrogen receptors α and β to partial estrogen agonists or antagonists. Mol. Pharmacol. 54:1998;105-112.
17. Hall J.M., McDonnell D.P. The estrogen receptor β-iso-form (ERβ) of the human estrogen receptor modulates ERα transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology. 140:1999;5566-5578.
18. Paech K., Webb P., Kuiper G.G., Nilsson S., Gustafsson J., Kushner P.J., Scanlan T.S. Differential ligand activation of estrogen receptors, ERα and ERβ, at AP1 sites. Science. 277:1997;1508-1510.
19. Webb P., Nguyen P., Valentine C., Lopez G.N., Kwok G.R., McInerney E., Katzenellenbogen B.S., Enmark E., Gustafsson J.-Å., Nilsson S., Kushner P.J. The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions. Mol. Endocrinol. 13:1999;1672-1685.
20. Qin C., Singh P., Safe S. Transcriptional activation of insulin-like growth factor binding protein 4 by 17β-estradiol in MCF-7 cells: role of estrogen receptor-Sp1 complexes. Endocrinology. 140:1999;2501-2508.
21. Wang W., Dong L., Saville B., Safe S. Transcriptional activation of E2F1 gene expression by 17β-estradiol in MCF-7 cells is regulated by NF-Y - Sp1-estrogen receptor interactions. Mol. Endocrinol. 13:1999;1373-1387.
22. Dong L., Wang W., Wang F., Stoner M., Reed J.C., Harigai M., Kladde M., Vyhlidal C., Safe S. Mechanisms of transcriptional activation of bcl-2 gene expression by 17β-estradiol in breast cancer cells. J. Biol. Chem. 174:1999;32099-32107.
23. Duan R., Porter W., Safe S. Estrogen-induced c-fos proto-oncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor-Sp1 complex formation. Endocrinology. 139:1998;1981-1990.
24. Sun G., Porter W., Safe S. Estrogen-induced retinoic acid receptor α1 gene expression: role of estrogen receptor-Sp1 complex. Mol. Endocrinol. 12:1998;882-890.
25. Saville B., Wormke M., Wang F., Nguyen T., Enmark E., Kuiper G., Gustafsson J.-A., Safe S. Ligand-, cell- and estrogen receptor-subtypes (α/β)-dependent activation at GC-rich (Sp1) promoter elements. J. Biol. Chem. 275:2000;5379-5387.
26. Robyr D., Wolffe A.P., Wahli W. Nuclear hormone receptor coregulators in action: diversity for shared tasks. Mol. Endocrinol. 14:2000;329-347.
27. McKenna N.J., O'Malley B.W. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell. 108:2002;465-474.
28. Klinge C.M. Estrogen receptor interactions with co-activators and corepressors. Steroids. 65:2000;227-251.
29. Brzozowski A.M., Pike A.C., Dauter Z., Hubbard R.E., Bonn T., Engstrom O., Ohman L., Greene G.L., Gustafsson J.A., Carlquist M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature. 389:1997;753-758.
30. Pike A.C., Brzozowski A.M., Hubbard R.E., Bonn T., Thorsell A.G., Engstrom O., Ljunggren J., Gustafsson J.A., Carlquist M. Structure of the ligand-binding domain of oestrogen receptor β in the presence of a partial agonist and a full antagonist. EMBO J. 18:1999;4608-4618.
31. Shiau A.K., Barstad D., Loria P.M., Cheng L., Kushner P.J., Agard D.A., Greene G.L. The structural basis of estrogen receptor-coactivator recognition and the antagonism of this interaction by tamoxifen. Cell. 95:1998;927-937.
32. Norris J.D., Paige L.A., Christensen D.J., Chang C.-Y., Huacani M.R., Fan D., Hamilton P.T., Fowlkes D.M., McDonnell D.P. Peptide antagonists of the human estrogen receptor. Science. 285:1999;744-746.
33. Paige L.A., Christensen D.J., Gron H., Norris J.D., Gottlin E.B., Padilla K.M., Change C.Y., Ballas L.M., Hamilton P.T., McDonnell D.P., Fowlkes D.M. Estrogen receptor (ER) modulators each induce distinct conformational changes in ERα and ERβ Proc. Natl. Acad. Sci. U.S.A. 96:1999;3999-4004.
34. Tzukerman M.T., Esty A., Santiso-Mere D., Danielian P., Parker M.G., Stein R.G., Pike J.W., McDonnell D.P. Human estrogen receptor transactivational capacity is determined by both cellular and promoter contexts and mediated by two functionally distinct intramolecular regions. Mol. Endocrinol. 8:1994;21-30.
35. McDonnell D.P., Clemm D.L., Hermann T., Goldman M.E., Pike J.W. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol. Endocrinol. 9:1995;659-669.
36. Hobson G.M., Molloy G.R., Benfield P.A. Identification of cis-acting regulatory elements in the promoter region of the rat brain creatine kinase gene. Mol. Cell. Biol. 10:1990;6533-6543.
37. Krishnan V., Porter W., Santostefano M., Wang X., Safe S. Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells. Mol. Cell. Biol. 15:1995;6710-6719.
38. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
39. Gould J.C., Leonard L.S., Maness S.C., Wagner B.L., Connor K., Zacharewski T., Safe S., McDonnell D.P., Gaido K.W. Bisphenol A interacts with the estrogen receptor α in a distinct manner from estradiol. Mol. Cell. Endocrinol. 142:1998;203-214.
40. Yoon K., Pallaroni L., Ramamoorthy K., Gaido K., Safe S. Ligand structure-dependent differences in activation of estrogen receptor α in human HepG2 liver and U2 osteogenic cancer cell lines. Mol. Cell. Endocrinol. 162:2000;211-220.
41. Cavailles V., Augereau P., Rochefort H. Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription. Proc. Natl. Acad. Sci. U.S.A. 90:1993;203-207.
42. Wu-Peng X.S., Pugliese T.E., Dickerson H.W., Pentecost B.T. Delineation of sites mediating estrogen regulation of the rat creatine kinase B gene. Mol. Endocrinol. 6:1992;231-240.
43. Sukovich D.A., Mukherjee R., Benfield P.A. A novel, cell-type specific mechanism for estrogen receptor-mediated gene activation in the absence of an estrogen-responsive element. Mol. Cell. Biol. 14:1994;7134-7143.
44. Wang F., Safe S. Transcriptional activation of rat creatine kinase B by 17β-estradiol in MCF-7 cells involves an estrogen responsive element and GC-rich sites. J. Cell Biochem. 84:2002;156-172.
45. Fisher B., Costantino J.P., Wickerham D.L., Redmond C.K., Kavanah M., Cronin W.M., Vogel V., Robidoux A., Dimitrov N., Atkins J., Daly M., Wieand S., Tan-Chiu E., Ford L., Wolmark N. Other National Surgical Adjuvant Breast and Bowel Project Investigators, tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. Natl. Cancer Inst. 90:1998;1371-1378.
46. Näär A.M., Lemon B.D., Tjian R. Transcriptional coactivator complexes. Annu. Rev. Biochem. 70:2001;475-501.
47. 3 receptor. J. Biol. Chem. 274:1999;16838-16845.